By KPC Mandere Onyinkwa The Kenya Medical Association (KMA) has announced its support for the introduction of lenacapavir as a new option for HIV pre-exposure prophylaxis (PrEP) in Kenya. KMA described the injectable drug as a groundbreaking addition to the country’s HIV prevention toolkit. The endorsement comes after two trials which showed that lenacapavir significantly […]